PCBEA3V Stock Latest News
Private CompaniesBeacon Therapeutics Receives 2026 Fierce 15 Recognition1d agoBEA3V
Private CompaniesBeacon Therapeutics to Highlight Laru-Zova Trial at Jefferies Healthcare Conference1w agoBEA3V
Private CompaniesBeacon Therapeutics Highlights Executive Participation in Retinal Disease Forum3w agoBEA3V
Private CompaniesBeacon Therapeutics Highlights Positive Pivotal Trial Results for XLRP Gene Therapy4w agoBEA3VPrivate CompaniesBeacon Therapeutics Advances Gene Therapy Program for Geographic Atrophy1M agoBEA3V
Private CompaniesBeacon Therapeutics Showcases VISTA XLRP Trial Data at Major Ophthalmology Meetings1M agoBEA3V
Private CompaniesBeacon Therapeutics Highlights Pivotal XLRP Gene Therapy Data Ahead of AAO 20261M agoBEA3V
Private CompaniesBeacon Therapeutics Emphasizes Mission in Ophthalmic Gene Therapy on World Sight Day1M agoBEA3V
Private CompaniesCommunity Engagement Underscores Clinical Progress in Ophthalmology Gene Therapy1M agoBEA3V
Private CompaniesBeacon Therapeutics Gains Recognition Following Gene Therapy Trial Progress1M agoBEA3V
Private CompaniesBeacon Therapeutics Highlights XLRP Gene Therapy Data at Euretina Congress1M agoBEA3V
Private CompaniesBeacon Therapeutics Reports Positive Pivotal Trial Results in XLRP Gene Therapy2M agoBEA3V
Private CompaniesBeacon Therapeutics CEO to Join Forum Discussion on Retinal Gene Therapy Advances2M agoBEA3V
Private CompaniesBeacon Therapeutics Highlights Upcoming VISTA Trial Milestone and Commercial Focus3M agoBEA3V
Private CompaniesBeacon Therapeutics Highlights Phase 2 DAWN Trial Progress for XLRP Gene Therapy4M agoBEA3V



